Pls. find enclosed herewith the Press Release regarding the Company''s wholly owned subsidiary.
DCAL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Dishman Carbogen Amcis Ltd's wholly-owned subsidiary, CARBOGEN AMCIS (Shanghai) Co. Ltd., has successfully cleared an unannounced Good Manufacturing Practice inspection by China's National Medical Products Administration. The inspection was conducted on April 14, 2026, and covered API manufacturing operations and the site's Quality System. No observations or issues were identified, which is a clean outcome. The Shanghai facility supports API manufacturing and process development within CARBOGEN AMCIS' global network. Company management called this a significant achievement that validates their global quality culture and confirms the site as a reliable partner for customers worldwide.
This is a positive regulatory validation for the subsidiary's operations, strengthening confidence in the company's quality standards. Passing an unannounced inspection with no observations supports business continuity in China and global pharmaceutical markets, which is beneficial for the parent company's outsourcing partnerships.